Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | TT3-LLN |
| Catalog Number | R-TT3-LLN |
| Alias | CAS:2922283-38-1 |
| Appearance | Milky to translucent nanosuspension |
| Molecular Formula | C93H177N3O3 |
| Solubility | Dispersed in specific sterile buffer |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | Drug delivery system development |
| Specification | 100mg:Inquiry 200mg:Inquiry 500mg:Inquiry |
| Description | TT3-LLN is an innovative drug delivery formulation that encapsulates the potent vesicular monoamine transporter 2 (VMAT2) inhibitor TT3 into lipid nanoparticles (LNP). TT3 itself, as a reversible VMAT2 inhibitor, is a powerful tool for studying monoaminergic nervous system function and Parkinson's disease models. However, its poor water solubility, in vivo distribution, and lack of targeting limit its application accuracy in research on specific brain regions and may cause systemic side effects. TT3-LLN is designed to address these challenges through advanced nanodelivery technology. |